Cargando…
A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer
SIMPLE SUMMARY: Gastrointestinal symptoms are a common reason for endoscopic referral. Symptoms alone are unreliable predictors of colorectal cancer (CRC), but as CRC prognosis relies mainly in an early diagnosis, many of these patients undergo colonoscopy. Therefore, most colonoscopies performed in...
Autores principales: | Hijos-Mallada, Gonzalo, Saura, Nuria, Lué, Alberto, Velamazan, Raúl, Nieto, Rocío, Navarro, Mercedes, Arechavaleta, Samantha, Chueca, Eduardo, Gomollon, Fernando, Lanas, Angel, Sostres, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913693/ https://www.ncbi.nlm.nih.gov/pubmed/36765678 http://dx.doi.org/10.3390/cancers15030721 |
Ejemplares similares
-
The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2021) -
A Patient Self-Made Point-of-Care Fecal Test Improves Diagnostic Accuracy Compared with Fecal Calprotectin Alone in Inflammatory Bowel Disease Patients
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2021) -
The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology
por: Lué, Alberto, et al.
Publicado: (2020) -
Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance
por: Navarro, Mercedes, et al.
Publicado: (2020) -
Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study
por: Lanas, Ángel, et al.
Publicado: (2023)